{"title":"[Population pharmacokinetics and its application in new drug research].","authors":"Wen-jun Chen, Tian-yan Zhou, Wei Lu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Population pharmacokinetics is an emerging discipline developed from the combination of\nclassical pharmacokinetic compartment model and statistics principles, which has been received more and more\nattention in recent years. Population pharmacokinetics plays important roles in all stages of new drug research.\nIn the early preclinical phase, population pharmacokinetic analysis can help to achieve the preliminary prediction\nof parameters from animal to human, optimize clinical trial designs, and shorten the time required for new\ndrugs from laboratory to clinical trials. In clinical trials and applications stage, population pharmacokinetic\nresearch can help researchers investigate the related covariates that affecting pharmacokinetic behavior of\npatients comprehensively, and find potential drug-drug interactions in clinical. In addition, population\npharmacokinetics has a unique advantage in pediatric drug development due to its strong analysis ability of\nsparse data. This paper provides a summary on the history and methods of population pharmacokinetics,\nand the application in new drug discovery and development.</p>","PeriodicalId":35924,"journal":{"name":"药学学报","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"药学学报","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Population pharmacokinetics is an emerging discipline developed from the combination of
classical pharmacokinetic compartment model and statistics principles, which has been received more and more
attention in recent years. Population pharmacokinetics plays important roles in all stages of new drug research.
In the early preclinical phase, population pharmacokinetic analysis can help to achieve the preliminary prediction
of parameters from animal to human, optimize clinical trial designs, and shorten the time required for new
drugs from laboratory to clinical trials. In clinical trials and applications stage, population pharmacokinetic
research can help researchers investigate the related covariates that affecting pharmacokinetic behavior of
patients comprehensively, and find potential drug-drug interactions in clinical. In addition, population
pharmacokinetics has a unique advantage in pediatric drug development due to its strong analysis ability of
sparse data. This paper provides a summary on the history and methods of population pharmacokinetics,
and the application in new drug discovery and development.
药学学报Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.20
自引率
0.00%
发文量
0
期刊介绍:
Acta Pharmaceutica Sinica B (APSB) is a bimonthly English peer-reviewed online journal in ScienceDirect, which publishes significant original research articles, communications and high quality reviews of recent advances. APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in 1953. The journal is co-published by Elsevier B.V., in association with the Institute of MateriaMedica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.